| P50 | author | Annick Mühlethaler-Mottet | Q60036047 |
| P2093 | author name string | Jean-Marc Joseph | |
| | Katia Balmas Bourloud | |
| | Katya Auderset | |
| | Marjorie Flahaut | |
| | Nicole Gross | |
| | Roland Meier | |
| P2860 | cites work | Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner | Q22008727 |
| | Inhibition of death receptor signals by cellular FLIP | Q24316446 |
| | Worms gang up on bacteria | Q27860588 |
| | Validating survivin as a cancer therapeutic target | Q28201382 |
| | Death and anti-death: tumour resistance to apoptosis | Q28217065 |
| | Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells | Q28254267 |
| | Death receptors: signaling and modulation | Q28280897 |
| | Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis | Q28511080 |
| | The biochemistry of apoptosis | Q29547741 |
| | IAP proteins: blocking the road to death's door | Q29619844 |
| | Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop | Q33186742 |
| | Molecular biology of neuroblastoma | Q33773346 |
| | Neuroblastoma: biological insights into a clinical enigma | Q34180699 |
| | Histone deacetylases and cancer: causes and therapies | Q34570082 |
| | Histone-deacetylase inhibitors: novel drugs for the treatment of cancer | Q34743301 |
| | Targeting death and decoy receptors of the tumour-necrosis factor superfamily | Q34791120 |
| | TNF-related apoptosis inducing ligand (TRAIL) and its receptors in tumor surveillance and cancer therapy | Q34807710 |
| | Cell surface Death Receptor signaling in normal and cancer cells | Q35091128 |
| | The histone deacetylase inhibitor suberic bishydroxamate: a potential sensitizer of melanoma to TNF-related apoptosis-inducing ligand (TRAIL) induced apoptosis. | Q35557641 |
| | Bcl-2-family proteins and the role of mitochondria in apoptosis | Q35595911 |
| | HDAC inhibitors for the treatment of cancer | Q35648783 |
| | Caspase cleavage of BimEL triggers a positive feedback amplification of apoptotic signaling | Q36017432 |
| | Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines | Q36060524 |
| | Persistent inhibition of FLIP(L) expression by lentiviral small hairpin RNA delivery restores death-receptor-induced apoptosis in neuroblastoma cells. | Q40311361 |
| | Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignancies. | Q40479108 |
| | Sensitization of osteosarcoma cells to death receptor-mediated apoptosis by HDAC inhibitors through downregulation of cellular FLIP. | Q40493042 |
| | Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1). | Q40533297 |
| | Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells | Q40543132 |
| | Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP. | Q40565103 |
| | Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol | Q40598265 |
| | Sensitization of mesothelioma to TRAIL apoptosis by inhibition of histone deacetylase: role of Bcl-xL down-regulation | Q40600722 |
| | Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. | Q43540223 |
| | Role of oxidant stress in the permeability transition induced in rat hepatic mitochondria by hydrophobic bile acids | Q43551171 |
| | Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells | Q44119535 |
| | Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia | Q44715109 |
| | Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation. | Q53668983 |
| | Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB. | Q53939117 |
| | The fundamental role of epigenetic events in cancer | Q56421597 |
| | Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway | Q58862256 |
| | Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells | Q58862259 |
| | Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN | Q73766132 |
| | Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis | Q74256185 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| | neuroblastoma | Q938205 |
| P304 | page(s) | 214 | |
| P577 | publication date | 2006-08-24 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio | |
| P478 | volume | 6 | |